Citigroup Maintains Neutral on Hims & Hers Health, Raises Price Target to $35

Benzinga · 1d ago
Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price target from $28 to $35.